Centro De Salud Cabra Matrona Antonia Mesa Fernandez
- Address
- lock Available on a paid plan
Cardiovascular Disease Research
At Centro De Salud Cabra Matrona Antonia Mesa Fernandez, investigators are exploring strategies to prevent heart failure and lower the risk of cardiovascular mortality in adults with elevated risk.
- Prevention of heart failure
- Combination inhaler therapy for cardiopulmonary outcomes
- Reducing cardiovascular death risk with novel agents
The studies aim to determine whether adding a new medication to standard treatment can significantly cut heart‑failure events, offering patients a safer therapeutic option.
Respiratory Tract Disease Research
The site is conducting trials focused on Chronic Obstructive Pulmonary Disease and Respiratory syncytial virus, seeking to improve outcomes for individuals with severe lung conditions.
- Antiviral efficacy assessment for RSV infection
- Inhaled triple therapy evaluation in COPD
- Enhancing safety for high‑risk respiratory patients
These trials test new antiviral therapy and optimized inhaler regimens to reduce symptoms and prevent complications in vulnerable populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro De Salud Cabra Matrona Antonia Mesa Fernandez
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial | AstraZeneca AB | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abelacimab | 1 | Unknown | 2023-10-31 | 2023-10-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.